These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11513907)

  • 41. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision].
    Dai YS; Li Q; Duanmu HJ
    Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sputum-smear-negative pulmonary tuberculosis: controlled trial of 3-month and 2-month regimens of chemotherapy.
    Lancet; 1979 Jun; 1(8131):1361-3. PubMed ID: 87829
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of patients for chronic pulmonary tuberculosis with expectoration--selection and tolerance to drugs].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):172-80. PubMed ID: 9489412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
    Koh WJ; Lee SH; Kang YA; Lee CH; Choi JC; Lee JH; Jang SH; Yoo KH; Jung KH; Kim KU; Choi SB; Ryu YJ; Chan Kim K; Um S; Kwon YS; Kim YH; Choi WI; Jeon K; Hwang YI; Kim SJ; Lee YS; Heo EY; Lee J; Ki YW; Shim TS; Yim JJ
    Am J Respir Crit Care Med; 2013 Oct; 188(7):858-64. PubMed ID: 23927582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.
    Jindani A; Nunn AJ; Enarson DA
    Lancet; 2004 Oct 2-8; 364(9441):1244-51. PubMed ID: 15464185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Additional evidence to support the phasing-out of treatment category II regimen for pulmonary tuberculosis in Peru.
    Ponce M; Ugarte-Gil C; Zamudio C; Krapp F; Gotuzzo E; Seas C
    Trans R Soc Trop Med Hyg; 2012 Aug; 106(8):508-10. PubMed ID: 22742941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of patients with chronic pulmonary tuberculosis with expectoration--evaluation of effectiveness].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):164-71. PubMed ID: 9489411
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delamanid for multidrug-resistant pulmonary tuberculosis.
    Gler MT; Skripconoka V; Sanchez-Garavito E; Xiao H; Cabrera-Rivero JL; Vargas-Vasquez DE; Gao M; Awad M; Park SK; Shim TS; Suh GY; Danilovits M; Ogata H; Kurve A; Chang J; Suzuki K; Tupasi T; Koh WJ; Seaworth B; Geiter LJ; Wells CD
    N Engl J Med; 2012 Jun; 366(23):2151-60. PubMed ID: 22670901
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multidrug-resistant tuberculosis and culture conversion with bedaquiline.
    Diacon AH; Pym A; Grobusch MP; de los Rios JM; Gotuzzo E; Vasilyeva I; Leimane V; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; De Paepe E; van Heeswijk RP; Dannemann B;
    N Engl J Med; 2014 Aug; 371(8):723-32. PubMed ID: 25140958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study.
    Keshavjee S; Gelmanova IY; Farmer PE; Mishustin SP; Strelis AK; Andreev YG; Pasechnikov AD; Atwood S; Mukherjee JS; Rich ML; Furin JJ; Nardell EA; Kim JY; Shin SS
    Lancet; 2008 Oct; 372(9647):1403-9. PubMed ID: 18723218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
    Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
    Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case series: initial outcome of persons with multidrug-resistant tuberculosis after treatment with the WHO standard retreatment regimen in Ho Chi Minh City, Vietnam.
    Lan NTN ; Lademarco MF; Binkin NJ; Tung LB; Quy HT; Cĵ NV
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):575-8. PubMed ID: 11409587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
    Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New drugs for tuberculosis.
    Grassi C; Peona V
    Eur Respir J Suppl; 1995 Sep; 20():714s-718s. PubMed ID: 8590571
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Incidence of resistance and risk factors for resistance in Mycobacterium tuberculosis. A retrospective study of 1,055 patients of a specialty hospital 1984 to 1993].
    Borchardt J; Kirsten D; Jörres R; Kroeger C; Magnussen H
    Pneumologie; 1996 Jan; 50(1):28-35. PubMed ID: 8774932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis.
    Park SK; Lee CM; Heu JP; Song SD
    Int J Tuberc Lung Dis; 2002 Feb; 6(2):143-9. PubMed ID: 11931413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.